Spleen Tyrosine Kinase Inhibition Mitigates Hemin-Induced Thromboinflammation in an Organ-Specific Manner in Sickle Cell Mice
Arteriosclerosis, Thrombosis, and Vascular Biology · 2025
DOI: 10.1161/atvbaha.124.322072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025. Verfasst von Juma El-Awaisi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Sciences, College of Medicine and Health, School of Medical Sciences, University of Birmingham, United Kingdom (J.E.-A.,…. Hauptthemen laut MEDLINE: Syk Kinase, Anemia, Sickle Cell, Protein Kinase Inhibitors, Spleen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Sickle cell disease (SCD) is a challenging genetic disorder characterized by hemolytic anemia, vaso-occlusive crises (VOC), and progressive organ damage. Despite its severity, effective treatments are limited. The recent withdrawal of promising therapies, such as the anti–P-selectin antibody Crizanlizumab and the hemoglobin polymerization inhibitor Voxelotor, highlights the urgent need for innovative approaches to alleviate vaso-occlusion and thromboinflammation. METHODS: In this study, we used advanced techniques, including intravital microscopy, laser speckle contrast imaging, and histological analysis, to examine the role of syk (spleen tyrosine kinase) in platelet and neutrophil recruitment, and blood perfusion in the lung, kidney, liver, and spleen of SCD mice. RESULTS: In the Berkeley SCD model, hemin-induced vaso-occlusion and impairment in pulmonary blood perfusion were independent of red cell congestion and fibrin deposition. Hypoperfusion was driven by adhesion of neutrophils and platelets in the microcirculation and exacerbated by pulmonary emboli. Hemin-induced cell adhesion and hypoperfusion were also observed in the renal microcirculation, whereas it was limited in the liver and spleen of SCD mice, suggesting that organ-specific mechanisms drive hypoperfusion and vaso-occlusion. To explore therapeutic options, we investigated the potential of Syk inhibition in improving blood perfusion and reducing thrombo-inflammation in different organs. Selective Syk inhibition, using BI-1002494, reduced cellular adhesion in the pulmonary and renal microvasculature, effectively restoring blood perfusion and reducing thrombo-inflammation. Low-dose Syk inhibitor was effective in reducing neutrophil adhesion and improving blood perfusion without inducing bleeding. Increasing the dose exacerbated hemin-induced bleeding in the lungs, likely due to off-target activity againt other kinases, including Src. CONCLUSIONS: These findings underscore the critical role of Syk in platelet and neutrophil mediated-thrombo-inflammation and hypoperfusion in SCD, suggesting that Syk inhibition is a promising strategy to reduce organ-specific vaso-occlusion, improve renal and pulmonary perfusion, and reduce organ damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Sciences, College of Medicine and Health, School of Medical Sciences, University of Birmingham, United Kingdom (J.E.-A., G.P., N.M., V.T., B.G., S.P.W., A.B., E.H., P.L.R.N., D.K., N.K., J.R…
- Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences, Institute of Pharmaceutical Science, King's College London, United Kingdom (S.J.C.).
- Centre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, The Midlands, United Kingdom (S.P.W.).
- Centre de Recherche des Cordeliers (CRC), INSERM, Sorbonne Université, Université Paris Cité (USPC), Université Paris Descartes, Université Paris Diderot Paris, France (J.D.D.).
ORCID-Profile: Juma El-Awaisi, Gina Perrella, Nicolas Mayor, Veronika Tinkova, Simon J Cleary, Beata Grygielska, Steve P Watson, Alexander Brill, Eman Hassan, Phillip L R Nicolson, Dean Kavanagh, Neena Kalia, Julie Rayes
Zitieren
APA
El-Awaisi, J., Perrella, G., Mayor, N., Tinkova, V., Cleary, S. J., Grygielska, B., Watson, S. P., Dimitrov, J. D., Brill, A., Hassan, E., Nicolson, P. L. R., Kavanagh, D., Kalia, N., & Rayes, J. (2025). Spleen Tyrosine Kinase Inhibition Mitigates Hemin-Induced Thromboinflammation in an Organ-Specific Manner in Sickle Cell Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.124.322072
Vancouver
El-Awaisi J, Perrella G, Mayor N, Tinkova V, Cleary SJ, Grygielska B, et al. Spleen Tyrosine Kinase Inhibition Mitigates Hemin-Induced Thromboinflammation in an Organ-Specific Manner in Sickle Cell Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025. doi:10.1161/atvbaha.124.322072
BibTeX
@article{ElAwaisi2025,
author = {El-Awaisi, Juma and Perrella, Gina and Mayor, Nicolas and Tinkova, Veronika and Cleary, Simon J and Grygielska, Beata and Watson, Steve P and Dimitrov, Jordan D and Brill, Alexander and Hassan, Eman and Nicolson, Phillip L R and Kavanagh, Dean and Kalia, Neena and Rayes, Julie},
title = {Spleen Tyrosine Kinase Inhibition Mitigates Hemin-Induced Thromboinflammation in an Organ-Specific Manner in Sickle Cell Mice},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2025},
doi = {10.1161/atvbaha.124.322072}
}
EUVIMED